Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "X-ray attenuation via high atomic number elements" describes the enhanced absorption or scattering (attenuation) of X-ray photons by materials composed of **elements with high atomic numbers** ('high-Z elements'), such as iodine, barium, tungsten, and lead[1][3][5][7]. These elements are used extensively both as X-ray tube anode targets (for producing X-rays at specific energies) and as contrast agents during imaging, where their high Z increases the probability of photoelectric interaction as a function of approx. \(Z^3\), leading to greater attenuation of X-rays[2][3]. In medical imaging, iodinated and barium-based compounds improve tissue contrast by differentially absorbing X-rays compared to surrounding tissues[3][5]. This is a **material property** manipulated for imaging and radiation shielding, not a discrete biological target, receptor, enzyme, or gene. "X-ray attenuation via high atomic number elements" is **not a canonical biological target** but a physical interaction leveraged in diagnostic imaging and radiation protection. It describes the increased X-ray absorption by materials (not biomolecules) containing atoms with high atomic numbers, with clinical applications in contrast imaging but no classification as a receptor, enzyme, etc.[1][3][5][7].
Agents with high atomic number (Z) (especially iodine and barium) attenuate X-rays more efficiently via the photoelectric effect, especially at energies near their K-edges, making them radiodense and thus suitable as contrast agents in imaging[3][5][7].
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on X-ray attenuation via high atomic number elements.